These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5056447)

  • 21. [A case of agranulocytosis possibly caused by alprenolol].
    Straatman E
    Ned Tijdschr Geneeskd; 1971 Nov; 115(46):1938-41. PubMed ID: 5148048
    [No Abstract]   [Full Text] [Related]  

  • 22. Alprenolol in the treatment of arrhythmias in acute coronary patients.
    Kreus KE; Salokannel SJ; Isomäki H; Waris EK
    Acta Med Scand; 1970 Nov; 188(5):375-8. PubMed ID: 4395252
    [No Abstract]   [Full Text] [Related]  

  • 23. Alprenolol treatment of angina pectoris.
    Nyberg KG
    JAMA; 1972 Apr; 220(1):128. PubMed ID: 5066752
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of beta-blocking agent in the treatment of peroperative cardiac arrhythmias in ophthalmo-surgery].
    Scaglioni P
    Minerva Oftalmol; 1968; 10(4):134-8. PubMed ID: 5717786
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.
    Duce BR; Garberg L; Smith ER
    Br J Pharmacol; 1970 Aug; 39(4):809-16. PubMed ID: 4394971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of heart arrhythmias in the acute phase of myocardial infarct with practolol].
    Kojoukharov DD
    G Ital Cardiol; 1972; 2(2):283-6. PubMed ID: 4401612
    [No Abstract]   [Full Text] [Related]  

  • 28. [The action of a drug with beta-blocking action on arrhythmias caused by cardio-version].
    Parenti G; Greggia G; Sacchetti F
    Cuore Circ; 1968 Oct; 52(5):260-70. PubMed ID: 4392542
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiarrhythmic activity of lidocaine and N-isopropyl-p-nitrophenylethanolamine (INPEA) in acetyl strophanthidin-induced arrhythmias.
    Paradise RR
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):482-93. PubMed ID: 6064573
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the mechanism of the antiarrhythmic effect of beta-adrenergic receptor blocking drugs. Experimental research using 2 isomers of butidrin].
    Mastandrea R; Malagnino G; Astorri E; Visoli O
    Boll Soc Ital Cardiol; 1967; 12(5):525-8. PubMed ID: 5606898
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective adrenergic beta-receptor blockade in the prevention of adrenaline-evoked ventricular arrhythmias in dogs anaesthetized with halothane in oxygen.
    Sharma PL
    Br J Anaesth; 1969 Jun; 41(6):481-8. PubMed ID: 5792880
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical uses of calcium ion antagonists in arrhythmias.
    Bender F
    Clin Invest Med; 1980; 3(1-2):21-8. PubMed ID: 7009001
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative evaluation of new drugs used in the treatment of cardiac arrhythmia.
    Doshchitsin VL
    Kardiologiia; 1975 Jan; 15(1):30-7. PubMed ID: 235035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic experiences with LB-46 (a new anti-arrhythmic agent) on arrhythmia during general anesthesia].
    Tosaki Y; Yoshiya I; Yoshikawa K; Onji Y
    Masui; 1971 Jan; 20(1):74-9. PubMed ID: 5102309
    [No Abstract]   [Full Text] [Related]  

  • 35. Chiral 2-amino-1-butanol xanthone derivatives as potential antiarrhythmic and hypotensive agents.
    Librowski T; Czarnecki R; Jastrzebska M
    Acta Pol Pharm; 1999; 56(1):87-90. PubMed ID: 10635353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of quinidine bisulfate in the prevention of paroxysmal cardic arrhythmia].
    Pasini U; Netto MP; Diament J; Valada LP
    Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(5):205-8. PubMed ID: 5081834
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
    Reynolds JL; Whitlock RM
    Br Heart J; 1972 Mar; 34(3):252-9. PubMed ID: 4111391
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new beta-receptor blockader as anti-arrhythmic agent].
    Dahlberg A
    Lakartidningen; 1972 Mar; 69(12):1334-5. PubMed ID: 4402107
    [No Abstract]   [Full Text] [Related]  

  • 39. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 40. New drugs for the treatment of cardiac arrhythmias.
    Bump TE; Arnsdorf MF
    Compr Ther; 1980 Jun; 6(6):63-72. PubMed ID: 6103779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.